Study confirms the therapeutic potential of inhibiting Aurora-A in cancer treatment
11/21/2013
Aurora-A is a protein involved in the cell division process that is highly expressed or synthesised in a large number of human cancers, especially in those associated with a bad prognosis. Several pharmaceutical companies have recently developed these protein inhibitors, although the therapeutic and physiological effects that blocking Aurora-A might have on adult tissues are still unknown.
Reducing risk of morning heart attack by taking aspirin at bedtime
11/21/2013
Taking aspirin at bedtime instead of in the morning might reduce acute heart events, according a new study presented at the American Heart Association's Scientific Sessions 2013.Low-dose daily aspirin is recommended for people at high risk of heart disease and for reducing the risk of recurrent heart events. Aspirin thins the blood and makes it less likely to clot.
Faster, cheaper diagnosis of sepsis
11/21/2013
A new method could cut hours off the time it takes to diagnose blood infections while also eliminating the need for complicated manual processing and expensive equipment, according to a report to be published in mBio®, the online open-access journal of the American Society for Microbiology.
Frailty in childhood cancer survivors
11/21/2013
Young adults who survived childhood cancer are more likely than their peers to be frail, according to a St. Jude Children's Research Hospital study, which reported the condition is more common among female survivors than women decades older. The research appears in the online edition of the Journal of Clinical Oncology.
Deep-space radiation hazards documented and quantified
11/21/2013
Scientists from the University of New Hampshire and colleagues have published comprehensive findings on space-based radiation as measured by a UNH-led detector aboard NASA's Lunar Reconnaissance Orbiter (LRO). The data provide critical information on the radiation hazards that will be faced by astronauts on extended missions to deep space such as those to Mars.
Immune system mutations found in breast cancers
11/21/2013
Mutations in the genes that defend the body against cancer-related viruses and other infections may play a larger role in breast cancer than previously thought, according to a study at the University of Illinois at Chicago.
Medical detection dogs: how they could save our lives in a sniff
11/20/2013
The term "man's best friend" is commonly used when it comes to dogs, and it is not hard to understand why. The loyalty of a dog toward its owner is something that cannot be questioned. But in recent years, the tables have turned and humans have become more reliant on dogs than ever before - to help save lives.According to The Humane Society of the United States, there are around 83.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced additional data for MK-3475, an investigational anti-PD-1 immunotherapy, in patients with advanced melanoma that showed an estimated overall survival rate of 81 percent at one year across all MK-3475 monotherapy doses evaluated.
Cancer charity breaks new ground with world's first under-18 donor
11/20/2013
Blood cancer charity Anthony Nolan has made an historic breakthrough in stem cell donation after it arranged for a donation from a 17-year-old girl.
New layer to the skin's fight against infection
11/20/2013
The layers of skin that form the first line of defence in the body's fight against infection have revealed a unanticipated secret.The single cell type that was thought to be behind the skin's immune defence has been found to have a doppelganger, with researchers from the Walter and Eliza Hall Institute showing the cells, despite appearing identical, are actually two different types.